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It is clear by now that health policy makers did not
devote the deserved attention to respiratory dis-
eases in the last decades. The five most important
respiratory diseases (COPD, asthma, lung cancer,
pneumonia and tuberculosis) are now responsible
for 20% of the mortality worldwide [1,2]. The annu-
al cost associated with these diseases amounts to 
€100 billion in Europe. Worldwide there are
presently about 300 million people with asthma
and 210 million persons with COPD and millions
more with a host of other lung diseases [3]. COPD
is now the fourth cause of death and is predicted to
become the third cause of death by 2030.
Respiratory diseases are also very important causes
of disability and reduction in health related quality
of life. Moreover, the mortality due to COPD has
doubled during the last three decades, whereas the
mortality due to cardiovascular disease and stroke
has decreased significantly [4].
Why did we deal better with cardiovascular dis-
eases and stroke in the last decade than with respi-
ratory disease? A host of reasons can probably be
offered as an explanation. For the purpose of the
present editorial, we will just present two. The first
and foremost reason is that although the major risk
factors for respiratory disease, i.e. smoking and air
pollution, have been known for a long time, we did
not really combat these risk factors vigorously.
Indeed, the recent Eurobarometer survey on smok-
ing [5] found that smoking prevalence is still high
in most European countries, with only Sweden ap-
proaching the presently optimal prevalence of
about 15% while the prevalence in other countries
like Spain and Greece still exceeds 35% and more.
Although the European Commission and the
European parliament have played a pivotal role in
triggering smoke-free legislation in the member
states, 2011 is only the first year in which the
growth of tobacco will not be subsidized by the
European Union. The second reason that I would
like to mention here is the deficient funding of re-
search on respiratory disease. In 2002 in the UK,
only 2.8% of the Medical Research Council budget
was dedicated to respiratory research, while respi-
ratory diseases represented 13% of the causes of
death [6]. Similarly, although the 7th Framework
Programme for Research and Technological devel-
opment, FP-7, devoted 4.3% of its budget to respi-
ratory disease, only 0.5% of the budget was spent
on research on asthma and COPD, quantitatively
the most important of the respiratory diseases.
For these reasons, the ERS participated last year in
the “Year of the Lung” proclaimed by all interna-
tional respiratory societies and organized several
events at the European Parliament in this context, to
raise awareness of respiratory diseases. One of
them was the first high level conference on Chronic
Respiratory Disease, under the Belgian Presidency,
which was held in Brussels in October last year [7].
These efforts have been successful as awareness of
respiratory disease with health policy makers is
now rising. Hence the time has now come to think
of the next steps: to identify the real issues, to de-
fine appropriate responses and to integrate these re-
sponses into the existing action plans like the
Europe 2020 plan. 
This is exactly why we took the initiative to develop
the European Respiratory Roadmap [8], a set of rec-
ommendations, guidelines and action plans, which
we offer to health policy makers in Europe in order
to deal better with respiratory diseases and to sub-
stantially improve their outlook in future. This doc-
ument comprises four sections: prevention, clinical
medicine, research and education. It was devel-
oped with the help of the entire Society: all
Assemblies, the Scientific School, Advocacy,
Tobacco control, and Environment committees, etc.
Its perspective was widened during a Summit held
in Leuven in March 2011 and, finally, all of the al-
most 12,000 members of our Society were invited
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to provide feedback. We proudly present the result
of this one-year-long process, which was officially
launched in a short, policy maker version in the
European Parliament on September 6th and then
was officially presented at the ERS annual meeting
in Amsterdam at the end of September. I thank our
Italian friends wholeheartedly for their help in the
dissemination of this document (see pp. 274-277 of
the present issue of Multidisciplinary Respiratory
Medicine), and I sincerely hope that this document
will fulfill its aim: to improve the outlook for respi-
ratory disease all over Europe.
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